Sweet's syndrome – a comprehensive review of an acute febrile neutrophilic dermatosis
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Sweet's syndrome (the eponym for acute febrile neutrophilic dermatosis) is characterized by a constellation of clinical symptoms, physical features, and pathologic findings which include fever, neutrophilia, tender erythematous skin lesions (papules, nodules, and plaques), and a diffuse infiltrate consisting predominantly of mature neutrophils that are typically located in the upper dermis. Several hundreds cases of Sweet's syndrome have been published. Sweet's syndrome presents in three clinical settings: classical (or idiopathic), malignancy-associated, and drug-induced. Classical Sweet's syndrome (CSS) usually presents in women between the age of 30 to 50 years, it is often preceded by an upper respiratory tract infection and may be associated with inflammatory bowel disease and pregnancy. Approximately one-third of patients with CSS experience recurrence of the dermatosis. The malignancy-associated Sweet's syndrome (MASS) can occur as a paraneoplastic syndrome in patients with an established cancer or individuals whose Sweet's syndrome-related hematologic dyscrasia or solid tumor was previously undiscovered; MASS is most commonly related to acute myelogenous leukemia. The dermatosis can precede, follow, or appear concurrent with the diagnosis of the patient's cancer. Hence, MASS can be the cutaneous harbinger of either an undiagnosed visceral malignancy in a previously cancer-free individual or an unsuspected cancer recurrence in an oncology patient. Drug-induced Sweet's syndrome (DISS) most commonly occurs in patients who have been treated with granulocyte-colony stimulating factor, however, other medications may also be associated with DISS. The pathogenesis of Sweet's syndrome may be multifactorial and still remains to be definitively established. Clinical and laboratory evidence suggests that cytokines have an etiologic role. Systemic corticosteroids are the therapeutic gold standard for Sweet's syndrome. After initiation of treatment with systemic corticosteroids, there is a prompt response consisting of dramatic improvement of both the dermatosis-related symptoms and skin lesions. Topical application of high potency corticosteroids or intralesional corticosteroids may be efficacious for treating localized lesions. Other first-line oral systemic agents are potassium iodide and colchicine. Second-line oral systemic agents include indomethacin, clofazimine, cyclosporine, and dapsone. The symptoms and lesions of Sweet's syndrome may resolved spontaneously, without any therapeutic intervention; however, recurrence may follow either spontaneous remission or therapy-induced clinical resolution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermatology in General Medicine.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-6-923_2 · Cited by 3,794
Fitzpatrick’s Dermatology in General Medicine
(1999) · Heart & Lung · doi:10.1016/s0147-9563(99)70018-x · Cited by 3,233
Fitzpatrick's Dermatology in General Medicine.
Cox, N. H. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.6032_1.x · Cited by 1,176
AN ACUTE FEBRILE NEUTROPHTLIC DERMATOSTS.
SWEET, R. B. (1964) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1964.tb14541.x · Cited by 1,049
Sweet's syndrome (acute febrile neutrophilic dermatosis)
Driesch, P. V. D. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(94)70215-2 · Cited by 655
Histologic Diagnosis of Inflammatory Skin Diseases.
(1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-6-1001_3 · Cited by 608
[Sweet's syndrome. Acute febrile neutrophilic dermatosis].
Bt, G., & Holm, J. O. (1987) · PubMed · Cited by 504
Walker, D. C., & Cohen, P. R. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90080-8 · Cited by 338
Self-citationSmith, R. A., Cokkinides, V., & Eyre, H. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.2.90 · Cited by 293
Kawakami, T., Ohashi, S., Kawa, Y., Takahama, H., Ito, M., Soma, Y., & Mizoguchi, M. (2004) · Archives of Dermatology · doi:10.1001/archderm.140.5.570 · Cited by 154
Cutaneous reactions to recombinant cytokine therapy
Asnis, L. A., & Gaspari, A. A. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)91382-3 · Cited by 123
Acute febrile neutrophilic dermatosis
Dr., N. L. P., & Levine, C. C. (2004) · Springer eBooks · doi:10.1007/3-540-29668-9_101 · Cited by 119
Thompson, D. F., & Montarella, K. E. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1h563 · Cited by 102
Wilson, D. M., John, G. R., & Callen, J. P. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70479-2 · Cited by 75
Matzkies, F. G., Manger, B., Schmitt-Haendle, M., Nagel, T., Kraetsch, H.-G., Kalden, J. R., & Schulze-Koops, H. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.1.81 · Cited by 63
MAGRO, C. M. J., Kiani, B., Li, J., & CROWSON, A. N. (2006) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2006.00654.x · Cited by 60
Sweet Syndrome in a Neonate with Aseptic Meningitis
Dunn, T. R., Saperstein, H., Biederman, A., & Kaplan, R. P. (1992) · Pediatric Dermatology · doi:10.1111/j.1525-1470.1992.tb00350.x · Cited by 60
Sweet’s Syndrome – An Extraintestinal Manifestation in Inflammatory Bowel Disease
Ytting, H., Vind, I., Bang, D., & Munkholm, P. S. (2005) · Digestion · doi:10.1159/000088466 · Cited by 59
Durani, B. K., & Jappe, U. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04817.x · Cited by 59
The Possible Role of G-CSF in the Pathogenesis of Sweet's Syndrome
Reuss-Borst, M. A., Müller, C. A., & Waller, H. D. (1994) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199409049722 · Cited by 58
MAGRO, C. M. J., Moraes, E. D., & Burns, F. (2001) · Journal of Cutaneous Pathology · doi:10.1034/j.1600-0560.2001.280205.x · Cited by 53
Morgan, K. W., & Callen, J. P. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.119032 · Cited by 50
Successful treatment of Sweet's syndrome with doxycycline
Joshi, R. K., Atukorala, D. N., Abanmi, A., Khamis, O., & Haleem, A. A. (1993) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1993.tb00242.x · Cited by 49
Bullous Sweet's syndrome in congenital neutropenia: Association with pegfilgrastim
Draper, B. K., Robbins, J. R., & Stricklin, G. P. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.12.028 · Cited by 44
Sáez, M., García-Bustínduy, M., Noda, A., Dorta, S., Escoda, M., Fagundo, E., Rodríguez, F., Guimerá, F., Sánchez, R., & García-Montelongo, R. (2004) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2004.00866.x · Cited by 41
Histologic Diagnosis of Inflammatory Skin Diseases: An Algorithmic Method Based on Pattern Analysis,
Weedon, D. D. (1999) · American Journal of Dermatopathology · doi:10.1097/00000372-199912000-00017 · Cited by 40
Neutrophilic Dermatosis (Sweet Syndrome) of the Hands Associated With Lenalidomide
Hoverson, A. R., Davis, M. D. P., Weenig, R. H., & Wolanskyj, A. P. (2006) · Archives of Dermatology · doi:10.1001/archderm.142.8.1070-b · Cited by 39
Jagdeo, J. R., Campbell, R., Long, T. P., Muglia, J. J., Telang, G. H., & Robinson‐Bostom, L. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.08.011 · Cited by 37
Kumar, G., Bernstein, J. M., Waibel, J. S., & Baumann, M. A. (2004) · American Journal of Hematology · doi:10.1002/ajh.20112 · Cited by 30
Sweet's syndrome following abacavir therapy
Giudice, P. D., Vandenbos, F., Perrin, C., Bernard, E., Marq, L., & Dellamonica, P. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.09.033 · Cited by 30
A Sweet-like syndrome manifesting as gingival hyperplasia and myositis without cutaneous involvement
Melinkeri, S. R., Gupta, R., & Dabadghao, S. S. (2002) · Annals of Hematology · doi:10.1007/s00277-002-0470-7 · Cited by 29
A distinctive vesiculopustular eruption associated with hepatobiliary disease
MAGRO, C. M. J., & CROWSON, A. N. (1997) · International Journal of Dermatology · doi:10.1046/j.1365-4362.1997.00010.x · Cited by 24
Granulocyte colony‐stimulating factor‐induced Sweet syndrome in a healthy donor
Oiso, N., Watanabe, K., & Kawada, A. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06222.x · Cited by 24
Ely, H. (1989) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(89)80143-4 · Cited by 23
Sweet's panniculitis associated with metastatic breast cancer
Teng, J. M. C., Draper, B. K., & Boyd, A. S. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.05.023 · Cited by 16
Particularités histologiques d’un cas de syndrome de Sweet déclenché par le G-CSF
Abecassis, S., Oro, S., Cavelier‐Balloy, B., Arnulf, B., Bachelez, H., & Dubertret, L. (2004) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/s0151-9638(04)93617-4 · Cited by 14
Neutrophilic dermatosis of the dorsal hands in a farmer
Aydin, F., Şentürk, N., Yıldız, L., et al. (2004) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2004.01059.x · Cited by 11
Granel‐Brocard, F., Barbraud, A., Schmutz, J. ‐., de Maistre, E., & Lecompte, T. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00252-1 · Cited by 3
Cited by
Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx008 · Cited by 1,910
Van Assche, G., Dignass, A., Reinisch, W., van der Woude, C. J., Sturm, A., De Vos, M., Guslandi, M., Oldenburg, B., Dotan, I., Marteau, P., et al. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.09.009 · Cited by 894
Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment
Pelosof, L. C., & Gerber, D. E. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0099 · Cited by 773
Van Assche, G., Dignass, A., Bokemeyer, B., Danese, S., Gionchetti, P., Moser, G., Beaugerie, L., Gomollón, F., Häuser, W., Herrlinger, K., et al. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.09.005 · Cited by 463
Larsen, S., Bendtzen, K., & Nielsen, O. H. (2010) · Annals of Medicine · doi:10.3109/07853890903559724 · Cited by 303
Metadata
- Authors
- Cohen, P. R.
- Venue
- Orphanet Journal of Rare Diseases
- Published
- 2007-07-26
- Volume
- 2
- Issue
- 1
- Pages
- 34-34
- ISSN
- 1750-1172 (ISSN-L)
- OpenAlex
- W2126086393
- Cited by
- 879
- References
- 38
- FWCI
- 16.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.